# Haleos Labs Ltd (HALEOSLABS)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1686.2
Day Change: +4.82%
52W High: ₹1774
52W Low: ₹1091.1
Market Cap: ₹471 Cr

## Valuation
P/E: 23.72
P/B: 2.28
EPS: ₹65.61
Book Value: ₹682.92
Dividend Yield: 0%

## Returns
1Y Return: 23.78%

## Profitability
ROE: 0%
ROCE: 14.91%
Debt/Equity: 0.31
Revenue Growth: 12%
Profit Growth: 21.1%
EBITDA Margin: 13.2%
Operating Margin: 10.7%

## About
Haleos Labs Ltd is a Biotechnology company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: Haleos Labs Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
- Announcement: Encumbrance (Annual Disclosure)
- BSE Filing: Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:02.224Z
Price History Updated: 2026-05-18T22:59:23.398Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:23.398Z
Quant Updated: 2026-05-18T22:59:23.398Z
Sentiment Updated: 2026-05-18T22:59:23.398Z
Financials Status: current
Financials Updated: 2026-05-19T13:31:31.425Z
Financials Last Attempt: 2026-05-19T13:31:31.425Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹336.78 Cr
Operating Profit: ₹30.13 Cr (OPM 8.95%)
Net Profit: ₹20.11 Cr
Tax: ₹7.46 Cr

## Annual P&L History
FY25: Rev ₹336.78Cr | PAT ₹20.11Cr | OPM 8.95%
FY24: Rev ₹299.56Cr | PAT ₹9.09Cr | OPM 5.43%
FY23: Rev ₹312.55Cr | PAT ₹11.46Cr | OPM 5.78%

## Balance Sheet (FY25)
Total Assets: ₹389.99 Cr
Total Liabilities: ₹177.94 Cr
Borrowings: ₹86.41 Cr
Cash: ₹0.5 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Talluri Veera Venkata Satyanarayana Murthy, MD & Executive Director
- Nadella Rajendra Prasad, CFO & GM of Accounts & Finance
- Trupti Ranjan Mohanty, Company Secretary & Compliance Officer
- Talluri Venkata Praveen, Chief Marketing Officer & Executive Director
- Sudeepthi  Gopineedi, Whole-Time Director

---
Source: rupiya.io/stocks/haleoslabs
Disclaimer: For research and education only. Not investment advice.